582P Preclinical development of AT1412, a patient derived CD9 antibody that does not induce thrombosis for treatment of precursor B ALL
| Autor: | Villaudy, J., Schotte, R., de Jong, G., Neviani, V., Pos, W., Levie, S., Yasuda, E., Cercel, M., Szabó, A., Fatmawati, C., Kedde, M., Horbach, S., Verdegaal, E.M.E., van Helden, P., van der Burg, S.H., Rijneveld, A., Gros, P., Spits, H., Hazenberg, M., van Eenennaam, H. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S493-S493 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|